News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

MimiVax Announces Positive Interim Results from Phase II Trial of SurVaxM Immunotherapy for the Treatment of Newly Diagnosed Glioblastoma

Al's Comment:

 Excellent results with a simple shot in the arm -and minimal side effects. This is the type of treatment that we need access to now - not years from now.


Posted on: 05/23/2018

MimiVax Announces Positive Interim Results from Phase II Trial of SurVaxM Immunotherapy for the Treatment of Newly Diagnosed Glioblastoma

https://globenewswire.com/news-release/2018/05/21/1509287/0/en/MimiVax-Announces-Positive-Interim-Results-from-Phase-II-Trial-of-SurVaxM-Immunotherapy-for-the-Treatment-of-Newly-Diagnosed-Glioblastoma.html

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740